| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Organ Prolapse | 6 | 2026 | 62 | 3.070 |
Why?
|
| Liver | 60 | 2026 | 1916 | 2.900 |
Why?
|
| Ligaments | 6 | 2026 | 76 | 2.780 |
Why?
|
| Cholestasis | 14 | 2026 | 217 | 1.980 |
Why?
|
| Mice | 150 | 2026 | 18491 | 1.780 |
Why?
|
| Mice, Inbred C57BL | 81 | 2026 | 6041 | 1.690 |
Why?
|
| Animals | 200 | 2026 | 38410 | 1.490 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 10 | 2022 | 266 | 1.390 |
Why?
|
| Ethanol | 21 | 2025 | 634 | 1.380 |
Why?
|
| Liver Diseases, Alcoholic | 11 | 2025 | 98 | 1.320 |
Why?
|
| Lipid Metabolism | 19 | 2026 | 538 | 1.320 |
Why?
|
| Hepatocytes | 11 | 2026 | 224 | 1.300 |
Why?
|
| Mice, Knockout | 46 | 2026 | 3153 | 1.230 |
Why?
|
| Fatty Liver | 14 | 2026 | 257 | 1.200 |
Why?
|
| Acetaminophen | 8 | 2026 | 269 | 1.150 |
Why?
|
| Oxidative Stress | 28 | 2026 | 1368 | 1.140 |
Why?
|
| Uterus | 6 | 2026 | 228 | 1.120 |
Why?
|
| Perilipin-2 | 13 | 2019 | 41 | 1.110 |
Why?
|
| Sacrum | 3 | 2026 | 80 | 1.050 |
Why?
|
| Bile Acids and Salts | 12 | 2026 | 163 | 0.990 |
Why?
|
| Disease Models, Animal | 46 | 2026 | 4604 | 0.970 |
Why?
|
| Chemical and Drug Induced Liver Injury | 8 | 2026 | 138 | 0.970 |
Why?
|
| Mast Cells | 5 | 2024 | 148 | 0.920 |
Why?
|
| Pelvic Floor | 1 | 2026 | 32 | 0.910 |
Why?
|
| Elastin | 1 | 2026 | 78 | 0.910 |
Why?
|
| Fructose | 11 | 2025 | 132 | 0.900 |
Why?
|
| Burns | 6 | 2025 | 374 | 0.890 |
Why?
|
| Receptors, Prostaglandin | 13 | 1998 | 21 | 0.890 |
Why?
|
| Obesity | 16 | 2025 | 3149 | 0.890 |
Why?
|
| Fructokinases | 9 | 2025 | 42 | 0.860 |
Why?
|
| Dinoprost | 15 | 1996 | 51 | 0.810 |
Why?
|
| Colon | 7 | 2025 | 310 | 0.800 |
Why?
|
| Inflammation | 22 | 2026 | 2920 | 0.790 |
Why?
|
| Kidney | 11 | 2026 | 1511 | 0.770 |
Why?
|
| Fatty Liver, Alcoholic | 5 | 2021 | 14 | 0.750 |
Why?
|
| Dietary Fats | 6 | 2026 | 309 | 0.740 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 5 | 2026 | 212 | 0.740 |
Why?
|
| Metabolic Syndrome | 7 | 2023 | 365 | 0.730 |
Why?
|
| Adipocytes | 6 | 2018 | 223 | 0.660 |
Why?
|
| Aldehyde Dehydrogenase | 7 | 2017 | 99 | 0.660 |
Why?
|
| Receptors, Estrogen | 2 | 2023 | 406 | 0.630 |
Why?
|
| Colitis | 4 | 2025 | 282 | 0.630 |
Why?
|
| Cytoplasm | 6 | 2016 | 255 | 0.630 |
Why?
|
| Intestinal Mucosa | 8 | 2025 | 676 | 0.630 |
Why?
|
| Glutathione | 10 | 2025 | 370 | 0.610 |
Why?
|
| Aldehydes | 10 | 2022 | 140 | 0.610 |
Why?
|
| Protein Carbonylation | 8 | 2018 | 57 | 0.600 |
Why?
|
| Milk | 7 | 2019 | 119 | 0.590 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 2019 | 10 | 0.580 |
Why?
|
| Immunity, Innate | 7 | 2026 | 840 | 0.560 |
Why?
|
| Alcoholic Intoxication | 3 | 2025 | 77 | 0.560 |
Why?
|
| Signal Transduction | 18 | 2026 | 5272 | 0.550 |
Why?
|
| Liver Diseases | 6 | 2024 | 307 | 0.550 |
Why?
|
| NF-kappa B | 7 | 2024 | 676 | 0.550 |
Why?
|
| Fructose Intolerance | 3 | 2024 | 5 | 0.550 |
Why?
|
| Chemical Warfare Agents | 6 | 2014 | 89 | 0.540 |
Why?
|
| Male | 91 | 2026 | 73950 | 0.530 |
Why?
|
| Macrophages | 9 | 2026 | 1529 | 0.530 |
Why?
|
| Liver Cirrhosis | 9 | 2025 | 289 | 0.530 |
Why?
|
| Skin | 9 | 2019 | 759 | 0.520 |
Why?
|
| Diet, High-Fat | 10 | 2026 | 267 | 0.510 |
Why?
|
| Mechlorethamine | 5 | 2015 | 52 | 0.510 |
Why?
|
| Neoplasm Proteins | 10 | 2005 | 445 | 0.510 |
Why?
|
| Membrane Proteins | 13 | 2025 | 1171 | 0.510 |
Why?
|
| Cholangitis, Sclerosing | 4 | 2024 | 61 | 0.510 |
Why?
|
| Antioxidants | 10 | 2023 | 550 | 0.510 |
Why?
|
| Carcinogenesis | 5 | 2025 | 230 | 0.500 |
Why?
|
| Alcohol Drinking | 5 | 2025 | 858 | 0.490 |
Why?
|
| Hibernation | 3 | 2026 | 82 | 0.480 |
Why?
|
| Lactation | 10 | 2019 | 195 | 0.480 |
Why?
|
| Lung | 11 | 2026 | 4141 | 0.470 |
Why?
|
| Mammary Glands, Animal | 7 | 2019 | 128 | 0.460 |
Why?
|
| Energy Metabolism | 7 | 2024 | 936 | 0.460 |
Why?
|
| Organelles | 2 | 2013 | 53 | 0.460 |
Why?
|
| Down Syndrome | 4 | 2026 | 526 | 0.450 |
Why?
|
| Glutathione Transferase | 6 | 2019 | 92 | 0.450 |
Why?
|
| Parenteral Nutrition | 5 | 2023 | 103 | 0.450 |
Why?
|
| Mitochondria | 7 | 2025 | 1000 | 0.430 |
Why?
|
| Dioxanes | 3 | 2024 | 11 | 0.430 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2025 | 379 | 0.430 |
Why?
|
| Cytochrome P-450 CYP2E1 | 6 | 2025 | 30 | 0.420 |
Why?
|
| DNA Damage | 8 | 2024 | 440 | 0.410 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2018 | 165 | 0.410 |
Why?
|
| Ovary | 4 | 2022 | 236 | 0.410 |
Why?
|
| Female | 68 | 2026 | 80076 | 0.390 |
Why?
|
| Prostaglandins F | 6 | 1988 | 15 | 0.380 |
Why?
|
| Oxidation-Reduction | 8 | 2026 | 1077 | 0.370 |
Why?
|
| Endotoxemia | 2 | 2024 | 86 | 0.370 |
Why?
|
| Colonic Neoplasms | 4 | 2025 | 258 | 0.360 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2024 | 1224 | 0.350 |
Why?
|
| Liver Neoplasms | 3 | 2025 | 787 | 0.350 |
Why?
|
| Fatty Acids | 5 | 2026 | 461 | 0.350 |
Why?
|
| Receptors, Virus | 2 | 2003 | 95 | 0.350 |
Why?
|
| Humans | 77 | 2026 | 147293 | 0.350 |
Why?
|
| Glutamate-Cysteine Ligase | 3 | 2025 | 19 | 0.350 |
Why?
|
| Peptides | 3 | 2008 | 1003 | 0.350 |
Why?
|
| Superoxide Dismutase | 6 | 2019 | 308 | 0.350 |
Why?
|
| Mustard Gas | 5 | 2014 | 77 | 0.340 |
Why?
|
| Diabetic Nephropathies | 3 | 2024 | 322 | 0.340 |
Why?
|
| Sciuridae | 3 | 2026 | 152 | 0.340 |
Why?
|
| Transfection | 8 | 2016 | 930 | 0.330 |
Why?
|
| Adenoviridae | 2 | 2003 | 199 | 0.330 |
Why?
|
| Glucose | 5 | 2026 | 1051 | 0.330 |
Why?
|
| Thioredoxin Reductase 1 | 3 | 2023 | 8 | 0.330 |
Why?
|
| Salmonella enterica | 2 | 2024 | 52 | 0.320 |
Why?
|
| Homocystinuria | 2 | 2024 | 62 | 0.320 |
Why?
|
| Endometrium | 6 | 1988 | 64 | 0.310 |
Why?
|
| Cell Proliferation | 12 | 2025 | 2529 | 0.310 |
Why?
|
| Apoptosis | 12 | 2025 | 2454 | 0.310 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2017 | 199 | 0.310 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2020 | 366 | 0.310 |
Why?
|
| Lens, Crystalline | 2 | 2022 | 136 | 0.310 |
Why?
|
| Rats | 19 | 2026 | 5613 | 0.310 |
Why?
|
| Glutathione Reductase | 3 | 2019 | 24 | 0.310 |
Why?
|
| Nitric Oxide Synthase Type I | 2 | 2020 | 30 | 0.300 |
Why?
|
| Lipid Peroxidation | 6 | 2025 | 169 | 0.300 |
Why?
|
| Heme Oxygenase-1 | 3 | 2025 | 76 | 0.300 |
Why?
|
| Precancerous Conditions | 2 | 2023 | 166 | 0.300 |
Why?
|
| Thioredoxins | 3 | 2018 | 30 | 0.300 |
Why?
|
| Fructose-Bisphosphate Aldolase | 3 | 2024 | 10 | 0.300 |
Why?
|
| Vagina | 2 | 2026 | 206 | 0.290 |
Why?
|
| AMP-Activated Protein Kinases | 4 | 2014 | 192 | 0.290 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2021 | 269 | 0.280 |
Why?
|
| Fallopian Tubes | 2 | 2022 | 33 | 0.280 |
Why?
|
| Sevelamer | 2 | 2020 | 9 | 0.280 |
Why?
|
| Ultraviolet Rays | 4 | 2022 | 385 | 0.280 |
Why?
|
| Epithelial Cells | 8 | 2025 | 1141 | 0.280 |
Why?
|
| Taste | 2 | 2021 | 238 | 0.280 |
Why?
|
| Pneumonia | 2 | 2025 | 636 | 0.270 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 2625 | 0.270 |
Why?
|
| Carbon Tetrachloride | 2 | 2025 | 13 | 0.270 |
Why?
|
| Skin Neoplasms | 3 | 2022 | 865 | 0.260 |
Why?
|
| Endothelial Cells | 2 | 2025 | 886 | 0.260 |
Why?
|
| Lung Injury | 2 | 2021 | 262 | 0.260 |
Why?
|
| Aldehyde Dehydrogenase, Mitochondrial | 5 | 2020 | 23 | 0.260 |
Why?
|
| STAT3 Transcription Factor | 2 | 2026 | 215 | 0.260 |
Why?
|
| Leptin | 2 | 2020 | 249 | 0.260 |
Why?
|
| Lipids | 7 | 2019 | 723 | 0.260 |
Why?
|
| Torpor | 2 | 2026 | 19 | 0.250 |
Why?
|
| Aging | 4 | 2025 | 1992 | 0.240 |
Why?
|
| Hepatic Stellate Cells | 2 | 2024 | 14 | 0.240 |
Why?
|
| Genetic Vectors | 4 | 2010 | 335 | 0.240 |
Why?
|
| Lactoylglutathione Lyase | 1 | 2026 | 22 | 0.240 |
Why?
|
| Kidney Diseases | 2 | 2023 | 428 | 0.240 |
Why?
|
| Cellular Senescence | 2 | 2026 | 229 | 0.240 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2024 | 480 | 0.240 |
Why?
|
| Ileum | 3 | 2024 | 112 | 0.240 |
Why?
|
| Triglycerides | 8 | 2021 | 529 | 0.240 |
Why?
|
| Diet | 4 | 2026 | 1284 | 0.240 |
Why?
|
| RNA, Messenger | 12 | 2023 | 2812 | 0.240 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2026 | 37 | 0.230 |
Why?
|
| Lauric Acids | 1 | 2026 | 8 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2019 | 440 | 0.230 |
Why?
|
| Lipid Droplets | 4 | 2019 | 24 | 0.230 |
Why?
|
| Blister | 4 | 2014 | 39 | 0.230 |
Why?
|
| Mice, Hairless | 9 | 2017 | 47 | 0.230 |
Why?
|
| Anti-Bacterial Agents | 3 | 2026 | 1940 | 0.230 |
Why?
|
| Cholangitis | 1 | 2026 | 22 | 0.230 |
Why?
|
| Irritants | 2 | 2017 | 42 | 0.230 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2025 | 12 | 0.230 |
Why?
|
| Calgranulin A | 1 | 2025 | 11 | 0.230 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 880 | 0.230 |
Why?
|
| Salmonella | 1 | 2026 | 51 | 0.230 |
Why?
|
| I-kappa B Proteins | 2 | 2022 | 75 | 0.230 |
Why?
|
| HEK293 Cells | 5 | 2021 | 745 | 0.230 |
Why?
|
| Aldehyde Oxidoreductases | 3 | 2010 | 28 | 0.220 |
Why?
|
| Immunohistochemistry | 13 | 2018 | 1730 | 0.220 |
Why?
|
| Salmonella Infections | 1 | 2026 | 58 | 0.220 |
Why?
|
| Glycoproteins | 4 | 2021 | 358 | 0.220 |
Why?
|
| Diet, Western | 3 | 2022 | 88 | 0.220 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2025 | 10 | 0.220 |
Why?
|
| Transduction, Genetic | 3 | 2003 | 133 | 0.220 |
Why?
|
| Scurvy | 1 | 2025 | 17 | 0.220 |
Why?
|
| Tensile Strength | 1 | 2025 | 98 | 0.220 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2025 | 81 | 0.220 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2025 | 21 | 0.220 |
Why?
|
| Colorectal Neoplasms | 2 | 2025 | 876 | 0.220 |
Why?
|
| Endoplasmic Reticulum | 5 | 2019 | 269 | 0.220 |
Why?
|
| Immunologic Surveillance | 1 | 2025 | 25 | 0.220 |
Why?
|
| Wnt-5a Protein | 1 | 2024 | 25 | 0.220 |
Why?
|
| Wnt3A Protein | 1 | 2024 | 11 | 0.220 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2025 | 103 | 0.210 |
Why?
|
| Mucosal-Associated Invariant T Cells | 1 | 2025 | 39 | 0.210 |
Why?
|
| Gentamicins | 1 | 2025 | 50 | 0.210 |
Why?
|
| Intra-Abdominal Fat | 1 | 2025 | 101 | 0.210 |
Why?
|
| Proteomics | 6 | 2024 | 1203 | 0.210 |
Why?
|
| Gene Dosage | 1 | 2025 | 145 | 0.210 |
Why?
|
| AMP Deaminase | 1 | 2024 | 11 | 0.210 |
Why?
|
| Silymarin | 2 | 2016 | 147 | 0.210 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2020 | 299 | 0.210 |
Why?
|
| Tetrahydrofolates | 1 | 2024 | 16 | 0.210 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2024 | 22 | 0.210 |
Why?
|
| Myofibroblasts | 1 | 2026 | 149 | 0.210 |
Why?
|
| Salmonella Phages | 1 | 2024 | 3 | 0.210 |
Why?
|
| Prophages | 1 | 2024 | 8 | 0.210 |
Why?
|
| Cachexia | 1 | 2025 | 74 | 0.210 |
Why?
|
| Paraffin Embedding | 1 | 2024 | 33 | 0.210 |
Why?
|
| Biopsy | 2 | 2026 | 1093 | 0.210 |
Why?
|
| Glycine | 2 | 2016 | 186 | 0.210 |
Why?
|
| Cell Line | 14 | 2022 | 2832 | 0.210 |
Why?
|
| Th17 Cells | 1 | 2025 | 103 | 0.210 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2024 | 17 | 0.210 |
Why?
|
| Carcinogens | 3 | 2024 | 123 | 0.200 |
Why?
|
| Formaldehyde | 1 | 2024 | 65 | 0.200 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2022 | 673 | 0.200 |
Why?
|
| Dietary Sucrose | 2 | 2023 | 50 | 0.200 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2024 | 773 | 0.200 |
Why?
|
| Gene Deletion | 4 | 2018 | 392 | 0.200 |
Why?
|
| Delivery, Obstetric | 1 | 2025 | 164 | 0.200 |
Why?
|
| Sphingosine | 1 | 2024 | 47 | 0.200 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2025 | 232 | 0.200 |
Why?
|
| Lipopolysaccharides | 2 | 2024 | 863 | 0.200 |
Why?
|
| Pancreatic Neoplasms | 4 | 2020 | 947 | 0.200 |
Why?
|
| Lung Neoplasms | 4 | 2026 | 2679 | 0.200 |
Why?
|
| Microtubule-Associated Proteins | 5 | 2019 | 197 | 0.200 |
Why?
|
| Transcription Factor AP-1 | 1 | 2024 | 79 | 0.200 |
Why?
|
| Digestive System Diseases | 1 | 2023 | 28 | 0.200 |
Why?
|
| Tandem Mass Spectrometry | 7 | 2024 | 575 | 0.200 |
Why?
|
| Glycolipids | 2 | 2016 | 53 | 0.200 |
Why?
|
| Ascorbic Acid | 1 | 2025 | 184 | 0.200 |
Why?
|
| Lysophospholipids | 1 | 2024 | 80 | 0.200 |
Why?
|
| Lipoproteins | 2 | 2021 | 166 | 0.200 |
Why?
|
| Endodeoxyribonucleases | 1 | 2024 | 77 | 0.200 |
Why?
|
| Oxygen | 3 | 2018 | 998 | 0.200 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2018 | 648 | 0.200 |
Why?
|
| NADPH Oxidases | 1 | 2024 | 123 | 0.190 |
Why?
|
| High Fructose Corn Syrup | 1 | 2023 | 9 | 0.190 |
Why?
|
| Animals, Newborn | 2 | 2024 | 914 | 0.190 |
Why?
|
| Azotemia | 1 | 2023 | 13 | 0.190 |
Why?
|
| Phagocytes | 1 | 2024 | 80 | 0.190 |
Why?
|
| Reperfusion Injury | 1 | 2026 | 294 | 0.190 |
Why?
|
| Collagen | 1 | 2026 | 460 | 0.190 |
Why?
|
| Autophagy | 3 | 2022 | 291 | 0.190 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2024 | 119 | 0.190 |
Why?
|
| Patched-1 Receptor | 2 | 2022 | 14 | 0.190 |
Why?
|
| Mitochondrial Proteins | 2 | 2015 | 264 | 0.190 |
Why?
|
| Estrogen Receptor beta | 1 | 2023 | 40 | 0.190 |
Why?
|
| Alprostadil | 4 | 1992 | 29 | 0.190 |
Why?
|
| Methionine | 1 | 2024 | 161 | 0.190 |
Why?
|
| Iron | 1 | 2025 | 361 | 0.190 |
Why?
|
| Wound Healing | 1 | 2026 | 361 | 0.190 |
Why?
|
| Corpus Luteum | 4 | 1992 | 23 | 0.190 |
Why?
|
| Myeloid Cells | 1 | 2024 | 150 | 0.190 |
Why?
|
| Herpesvirus 3, Human | 2 | 2021 | 343 | 0.190 |
Why?
|
| Interleukin-6 | 5 | 2025 | 784 | 0.190 |
Why?
|
| Oxidative Phosphorylation | 3 | 2021 | 212 | 0.190 |
Why?
|
| Cell Membrane | 5 | 2016 | 711 | 0.190 |
Why?
|
| Extracellular Vesicles | 1 | 2025 | 175 | 0.190 |
Why?
|
| Catalase | 3 | 2017 | 134 | 0.190 |
Why?
|
| Middle Aged | 12 | 2026 | 36821 | 0.190 |
Why?
|
| Antidotes | 2 | 2015 | 145 | 0.190 |
Why?
|
| Pseudomonas Infections | 1 | 2025 | 231 | 0.190 |
Why?
|
| Phospholipids | 2 | 2017 | 214 | 0.190 |
Why?
|
| Acute Lung Injury | 1 | 2026 | 312 | 0.180 |
Why?
|
| Dermatitis, Contact | 2 | 2013 | 18 | 0.180 |
Why?
|
| Urinary Tract Infections | 1 | 2025 | 212 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2024 | 334 | 0.180 |
Why?
|
| Nucleotides | 2 | 2021 | 129 | 0.180 |
Why?
|
| Proteins | 6 | 2013 | 1024 | 0.180 |
Why?
|
| Immune Tolerance | 1 | 2025 | 386 | 0.180 |
Why?
|
| Membrane Glycoproteins | 4 | 2021 | 499 | 0.180 |
Why?
|
| Alcoholism | 2 | 2022 | 838 | 0.180 |
Why?
|
| Phosphorylation | 6 | 2020 | 1721 | 0.180 |
Why?
|
| Postpartum Period | 1 | 2025 | 379 | 0.180 |
Why?
|
| Weight Gain | 4 | 2019 | 566 | 0.180 |
Why?
|
| Receptors, Androgen | 1 | 2023 | 149 | 0.180 |
Why?
|
| Abdominal Injuries | 1 | 2023 | 130 | 0.180 |
Why?
|
| Cytokines | 6 | 2025 | 2086 | 0.180 |
Why?
|
| Blotting, Western | 9 | 2015 | 1186 | 0.180 |
Why?
|
| Thermogenesis | 2 | 2019 | 45 | 0.180 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2021 | 16 | 0.170 |
Why?
|
| Estrogen Receptor alpha | 1 | 2023 | 154 | 0.170 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2022 | 50 | 0.170 |
Why?
|
| Phytosterols | 1 | 2021 | 10 | 0.170 |
Why?
|
| Bacterial Toxins | 1 | 2022 | 109 | 0.170 |
Why?
|
| Isoxazoles | 1 | 2021 | 56 | 0.170 |
Why?
|
| Energy Intake | 3 | 2021 | 514 | 0.170 |
Why?
|
| Viral Proteins | 1 | 2024 | 353 | 0.170 |
Why?
|
| Drug Delivery Systems | 1 | 2025 | 381 | 0.170 |
Why?
|
| Estrogens | 2 | 2023 | 368 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2025 | 932 | 0.170 |
Why?
|
| Glycolysis | 4 | 2025 | 341 | 0.170 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 375 | 0.170 |
Why?
|
| Drug Resistance | 1 | 2022 | 145 | 0.170 |
Why?
|
| Adipose Tissue, Brown | 2 | 2019 | 60 | 0.170 |
Why?
|
| Neutrophils | 2 | 2024 | 1135 | 0.170 |
Why?
|
| Pneumococcal Infections | 1 | 2022 | 106 | 0.170 |
Why?
|
| Adrenal Glands | 1 | 2021 | 77 | 0.170 |
Why?
|
| Peroxiredoxins | 2 | 2018 | 25 | 0.170 |
Why?
|
| Phenylurea Compounds | 1 | 2022 | 122 | 0.160 |
Why?
|
| Hepatitis | 2 | 2019 | 43 | 0.160 |
Why?
|
| Receptors, Vasopressin | 1 | 2021 | 20 | 0.160 |
Why?
|
| Eye | 1 | 2022 | 112 | 0.160 |
Why?
|
| 3T3 Cells | 4 | 2003 | 157 | 0.160 |
Why?
|
| Mucoproteins | 1 | 2020 | 8 | 0.160 |
Why?
|
| Janus Kinase 1 | 1 | 2020 | 26 | 0.160 |
Why?
|
| Janus Kinase 2 | 1 | 2020 | 31 | 0.160 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 3 | 2016 | 56 | 0.160 |
Why?
|
| Azetidines | 1 | 2020 | 45 | 0.160 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 268 | 0.160 |
Why?
|
| Momordica charantia | 1 | 2020 | 14 | 0.160 |
Why?
|
| Kidney Tubules | 2 | 2019 | 118 | 0.160 |
Why?
|
| Vasopressins | 1 | 2021 | 61 | 0.160 |
Why?
|
| Quinolines | 1 | 2022 | 192 | 0.160 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 17 | 0.160 |
Why?
|
| Uric Acid | 1 | 2021 | 168 | 0.160 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2020 | 40 | 0.160 |
Why?
|
| Sulfonamides | 2 | 2023 | 596 | 0.160 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2016 | 340 | 0.160 |
Why?
|
| Biomarkers, Tumor | 3 | 2016 | 1339 | 0.160 |
Why?
|
| Gene Expression | 2 | 2023 | 1481 | 0.160 |
Why?
|
| Monocytes | 2 | 2021 | 539 | 0.150 |
Why?
|
| Case-Control Studies | 5 | 2020 | 3660 | 0.150 |
Why?
|
| Lipoproteins, LDL | 1 | 2020 | 119 | 0.150 |
Why?
|
| Head and Neck Neoplasms | 1 | 2025 | 569 | 0.150 |
Why?
|
| Sugars | 1 | 2020 | 40 | 0.150 |
Why?
|
| Herpesviridae Infections | 1 | 2021 | 148 | 0.150 |
Why?
|
| Biomarkers | 7 | 2023 | 4351 | 0.150 |
Why?
|
| Melanocytes | 1 | 2020 | 65 | 0.150 |
Why?
|
| Myometrium | 1 | 2020 | 38 | 0.150 |
Why?
|
| Lymphatic Vessels | 1 | 2020 | 63 | 0.150 |
Why?
|
| Lysine | 2 | 2024 | 305 | 0.150 |
Why?
|
| PPAR alpha | 3 | 2016 | 56 | 0.150 |
Why?
|
| Up-Regulation | 6 | 2022 | 848 | 0.150 |
Why?
|
| Intestines | 3 | 2020 | 356 | 0.150 |
Why?
|
| SNARE Proteins | 1 | 2019 | 42 | 0.150 |
Why?
|
| Electron Microscope Tomography | 1 | 2019 | 41 | 0.150 |
Why?
|
| Gastrointestinal Motility | 1 | 2019 | 29 | 0.150 |
Why?
|
| Cholesterol | 5 | 2022 | 410 | 0.150 |
Why?
|
| Sucrose | 3 | 2018 | 114 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 1 | 2020 | 182 | 0.150 |
Why?
|
| Cholesterol, Dietary | 1 | 2019 | 15 | 0.150 |
Why?
|
| Body Weight Maintenance | 1 | 2019 | 18 | 0.150 |
Why?
|
| Protein Biosynthesis | 3 | 2001 | 452 | 0.140 |
Why?
|
| Adipose Tissue | 3 | 2019 | 646 | 0.140 |
Why?
|
| Bacterial Proteins | 1 | 2026 | 976 | 0.140 |
Why?
|
| Blood Glucose | 3 | 2026 | 2359 | 0.140 |
Why?
|
| Deoxycytidine | 1 | 2020 | 220 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 552 | 0.140 |
Why?
|
| Acylation | 1 | 2019 | 30 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2020 | 915 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2020 | 536 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 1457 | 0.140 |
Why?
|
| Kupffer Cells | 1 | 2019 | 52 | 0.140 |
Why?
|
| Models, Animal | 2 | 2022 | 394 | 0.140 |
Why?
|
| Leishmania major | 1 | 2018 | 8 | 0.140 |
Why?
|
| Emphysema | 1 | 2019 | 100 | 0.140 |
Why?
|
| Nitric Oxide | 3 | 2020 | 892 | 0.140 |
Why?
|
| Arousal | 2 | 2026 | 158 | 0.140 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2019 | 77 | 0.140 |
Why?
|
| Altitude Sickness | 1 | 2020 | 142 | 0.140 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2019 | 178 | 0.140 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2018 | 14 | 0.140 |
Why?
|
| Adult | 11 | 2026 | 41405 | 0.140 |
Why?
|
| Plant Extracts | 1 | 2020 | 191 | 0.140 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 201 | 0.140 |
Why?
|
| Chromatography, Liquid | 5 | 2024 | 453 | 0.140 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2018 | 14 | 0.140 |
Why?
|
| Arteries | 1 | 2020 | 262 | 0.140 |
Why?
|
| Protein Kinases | 1 | 2020 | 312 | 0.140 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 59 | 0.140 |
Why?
|
| Adipose Tissue, White | 1 | 2018 | 43 | 0.140 |
Why?
|
| Bile Ducts | 1 | 2018 | 68 | 0.140 |
Why?
|
| Intestine, Small | 2 | 2020 | 168 | 0.130 |
Why?
|
| Cell Line, Tumor | 6 | 2026 | 3565 | 0.130 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2018 | 31 | 0.130 |
Why?
|
| Base Sequence | 6 | 2015 | 2175 | 0.130 |
Why?
|
| Hep G2 Cells | 4 | 2021 | 73 | 0.130 |
Why?
|
| Phenotype | 3 | 2023 | 3216 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 122 | 0.130 |
Why?
|
| Desoxycorticosterone Acetate | 1 | 2017 | 4 | 0.130 |
Why?
|
| Amino Acid Sequence | 7 | 2020 | 2134 | 0.130 |
Why?
|
| Adenocarcinoma | 3 | 2011 | 928 | 0.130 |
Why?
|
| Relaxin | 1 | 2017 | 18 | 0.130 |
Why?
|
| Hypersensitivity | 1 | 2020 | 254 | 0.130 |
Why?
|
| Glucosides | 1 | 2018 | 56 | 0.130 |
Why?
|
| Cold Temperature | 1 | 2019 | 207 | 0.130 |
Why?
|
| Acetyl-CoA Carboxylase | 2 | 2014 | 32 | 0.130 |
Why?
|
| Thyroid Neoplasms | 1 | 2022 | 380 | 0.130 |
Why?
|
| Phosphatidylethanolamine N-Methyltransferase | 1 | 2017 | 8 | 0.130 |
Why?
|
| Insulin Resistance | 4 | 2019 | 1253 | 0.130 |
Why?
|
| Benzhydryl Compounds | 1 | 2018 | 81 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 2627 | 0.130 |
Why?
|
| Breast Neoplasms | 2 | 2026 | 2420 | 0.130 |
Why?
|
| Phosgene | 1 | 2017 | 5 | 0.130 |
Why?
|
| Cytochrome d Group | 1 | 2016 | 2 | 0.130 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 267 | 0.130 |
Why?
|
| Oximes | 1 | 2017 | 26 | 0.130 |
Why?
|
| Virulence Factors | 1 | 2018 | 175 | 0.120 |
Why?
|
| Cytochrome b Group | 1 | 2016 | 22 | 0.120 |
Why?
|
| Metabolomics | 5 | 2024 | 736 | 0.120 |
Why?
|
| DNA Primers | 5 | 2015 | 505 | 0.120 |
Why?
|
| Vasodilation | 1 | 2020 | 522 | 0.120 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 114 | 0.120 |
Why?
|
| Zebrafish Proteins | 1 | 2020 | 316 | 0.120 |
Why?
|
| Transcription, Genetic | 3 | 2005 | 1456 | 0.120 |
Why?
|
| Nephrosclerosis | 1 | 2016 | 6 | 0.120 |
Why?
|
| Apocrine Glands | 1 | 2016 | 5 | 0.120 |
Why?
|
| Reactive Oxygen Species | 3 | 2022 | 616 | 0.120 |
Why?
|
| Mitochondria, Muscle | 1 | 2018 | 125 | 0.120 |
Why?
|
| Metalloporphyrins | 2 | 2014 | 63 | 0.120 |
Why?
|
| Temperature | 2 | 2018 | 638 | 0.120 |
Why?
|
| Xanthine Dehydrogenase | 1 | 2016 | 24 | 0.120 |
Why?
|
| Spleen | 2 | 2018 | 509 | 0.120 |
Why?
|
| Cells, Cultured | 10 | 2020 | 4169 | 0.120 |
Why?
|
| Biliary Atresia | 1 | 2018 | 163 | 0.120 |
Why?
|
| Molecular Sequence Data | 7 | 2015 | 2886 | 0.120 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2016 | 47 | 0.120 |
Why?
|
| Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 11 | 0.120 |
Why?
|
| Necrosis | 2 | 2015 | 245 | 0.120 |
Why?
|
| Rabbits | 10 | 2002 | 654 | 0.120 |
Why?
|
| Mice, Obese | 3 | 2023 | 68 | 0.120 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2018 | 178 | 0.120 |
Why?
|
| Proteome | 2 | 2019 | 520 | 0.120 |
Why?
|
| End Stage Liver Disease | 1 | 2017 | 95 | 0.120 |
Why?
|
| Disease Susceptibility | 2 | 2020 | 347 | 0.120 |
Why?
|
| Cell Differentiation | 7 | 2020 | 2054 | 0.120 |
Why?
|
| Optical Imaging | 1 | 2016 | 63 | 0.120 |
Why?
|
| Disease Progression | 6 | 2020 | 2890 | 0.120 |
Why?
|
| Acetylcysteine | 2 | 2022 | 139 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1996 | 82 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 855 | 0.120 |
Why?
|
| Choline | 1 | 2017 | 138 | 0.120 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2015 | 19 | 0.120 |
Why?
|
| Microbiota | 1 | 2023 | 736 | 0.110 |
Why?
|
| Epithelium, Corneal | 1 | 2016 | 41 | 0.110 |
Why?
|
| Recombinant Proteins | 3 | 2017 | 1371 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2022 | 524 | 0.110 |
Why?
|
| Cell Division | 7 | 1988 | 758 | 0.110 |
Why?
|
| Zebrafish | 1 | 2020 | 536 | 0.110 |
Why?
|
| Estradiol | 4 | 1988 | 515 | 0.110 |
Why?
|
| Fibrosis | 4 | 2022 | 568 | 0.110 |
Why?
|
| Down-Regulation | 4 | 2022 | 618 | 0.110 |
Why?
|
| Peroxidase | 5 | 2015 | 168 | 0.110 |
Why?
|
| Space Flight | 1 | 2016 | 72 | 0.110 |
Why?
|
| Epidermis | 2 | 2014 | 156 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 2973 | 0.110 |
Why?
|
| Chemokines | 3 | 2023 | 217 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2021 | 694 | 0.110 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2016 | 145 | 0.110 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 2197 | 0.110 |
Why?
|
| Skin Diseases | 1 | 2017 | 152 | 0.110 |
Why?
|
| Hematopoietic System | 1 | 2014 | 7 | 0.110 |
Why?
|
| Pelvis | 1 | 2016 | 129 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 409 | 0.110 |
Why?
|
| Cytoprotection | 2 | 2015 | 56 | 0.110 |
Why?
|
| Heart Defects, Congenital | 1 | 2023 | 941 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 889 | 0.110 |
Why?
|
| Alanine Transaminase | 4 | 2016 | 151 | 0.110 |
Why?
|
| Acetylation | 3 | 2024 | 262 | 0.110 |
Why?
|
| Homocysteine | 3 | 2024 | 152 | 0.100 |
Why?
|
| Body Weight | 5 | 2016 | 976 | 0.100 |
Why?
|
| Mice, Inbred ICR | 3 | 2021 | 113 | 0.100 |
Why?
|
| Fetal Growth Retardation | 1 | 2020 | 594 | 0.100 |
Why?
|
| Motor Activity | 1 | 2019 | 719 | 0.100 |
Why?
|
| Breast Feeding | 1 | 2018 | 447 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 984 | 0.100 |
Why?
|
| Cloning, Molecular | 4 | 2010 | 539 | 0.100 |
Why?
|
| Hyperkeratosis, Epidermolytic | 1 | 2014 | 21 | 0.100 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2013 | 9 | 0.100 |
Why?
|
| Dermis | 1 | 2014 | 33 | 0.100 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2014 | 42 | 0.100 |
Why?
|
| Grape Seed Extract | 1 | 2013 | 29 | 0.100 |
Why?
|
| Stilbenes | 1 | 2013 | 30 | 0.100 |
Why?
|
| Tongue Neoplasms | 1 | 2013 | 26 | 0.100 |
Why?
|
| Methylation | 1 | 2014 | 242 | 0.100 |
Why?
|
| Heart | 1 | 2017 | 628 | 0.100 |
Why?
|
| Prediabetic State | 1 | 2016 | 251 | 0.100 |
Why?
|
| Macrophage Activation | 3 | 2023 | 181 | 0.100 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2014 | 129 | 0.100 |
Why?
|
| Melanoma | 1 | 2020 | 774 | 0.100 |
Why?
|
| Aged | 7 | 2024 | 26514 | 0.100 |
Why?
|
| Heme | 2 | 2025 | 90 | 0.100 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 63 | 0.100 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1996 | 149 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2013 | 337 | 0.100 |
Why?
|
| Isoproterenol | 1 | 2013 | 96 | 0.090 |
Why?
|
| Protein Structure, Secondary | 3 | 2018 | 372 | 0.090 |
Why?
|
| Weight Loss | 1 | 2019 | 867 | 0.090 |
Why?
|
| Organ Size | 4 | 2016 | 465 | 0.090 |
Why?
|
| Feces | 3 | 2024 | 500 | 0.090 |
Why?
|
| Inositol Phosphates | 3 | 1988 | 21 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 3 | 2011 | 407 | 0.090 |
Why?
|
| Lymphopenia | 1 | 2013 | 62 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 481 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 878 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2016 | 156 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 135 | 0.090 |
Why?
|
| Pregnancy | 7 | 2025 | 7274 | 0.090 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 2 | 2003 | 8 | 0.090 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 79 | 0.090 |
Why?
|
| Natural Killer T-Cells | 1 | 2013 | 71 | 0.090 |
Why?
|
| Cattle | 6 | 2016 | 948 | 0.090 |
Why?
|
| Testis | 1 | 1992 | 165 | 0.090 |
Why?
|
| Myocardium | 1 | 2017 | 947 | 0.090 |
Why?
|
| Carrier Proteins | 3 | 2017 | 731 | 0.090 |
Why?
|
| Mothers | 2 | 2018 | 774 | 0.090 |
Why?
|
| Perilipin-3 | 2 | 2008 | 4 | 0.090 |
Why?
|
| Mammals | 2 | 2023 | 286 | 0.090 |
Why?
|
| Reactive Nitrogen Species | 1 | 2011 | 16 | 0.080 |
Why?
|
| DNA, Complementary | 3 | 2016 | 273 | 0.080 |
Why?
|
| Taurine | 1 | 2011 | 41 | 0.080 |
Why?
|
| Transcription Factors | 4 | 2025 | 1747 | 0.080 |
Why?
|
| Olfactory Mucosa | 1 | 2011 | 40 | 0.080 |
Why?
|
| Administration, Cutaneous | 3 | 2017 | 127 | 0.080 |
Why?
|
| Eye Proteins | 2 | 2021 | 93 | 0.080 |
Why?
|
| Microtubules | 1 | 2013 | 267 | 0.080 |
Why?
|
| Ligands | 2 | 2023 | 675 | 0.080 |
Why?
|
| Nasal Cavity | 1 | 2011 | 61 | 0.080 |
Why?
|
| beta Catenin | 2 | 2024 | 254 | 0.080 |
Why?
|
| Acetaldehyde | 1 | 2010 | 17 | 0.080 |
Why?
|
| Blood Proteins | 1 | 2012 | 239 | 0.080 |
Why?
|
| Mutation | 3 | 2020 | 4130 | 0.080 |
Why?
|
| Chenodeoxycholic Acid | 2 | 2021 | 12 | 0.080 |
Why?
|
| Luminescent Proteins | 2 | 2001 | 187 | 0.080 |
Why?
|
| Neurons | 1 | 2019 | 1672 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 980 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 3 | 2018 | 1266 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2020 | 6099 | 0.080 |
Why?
|
| Betaine | 2 | 2024 | 67 | 0.080 |
Why?
|
| Casein Kinase II | 1 | 2009 | 22 | 0.080 |
Why?
|
| COS Cells | 2 | 2003 | 177 | 0.070 |
Why?
|
| Immediate-Early Proteins | 1 | 2009 | 46 | 0.070 |
Why?
|
| Protein Folding | 1 | 2011 | 280 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 669 | 0.070 |
Why?
|
| Peroxiredoxin VI | 1 | 2009 | 9 | 0.070 |
Why?
|
| DNA-Binding Proteins | 3 | 2025 | 1488 | 0.070 |
Why?
|
| Hyaluronan Receptors | 1 | 2009 | 105 | 0.070 |
Why?
|
| Lysosomes | 2 | 2019 | 133 | 0.070 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2008 | 26 | 0.070 |
Why?
|
| Viral Envelope Proteins | 1 | 2009 | 98 | 0.070 |
Why?
|
| Serine | 1 | 2009 | 143 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 3 | 2020 | 512 | 0.070 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2014 | 49 | 0.070 |
Why?
|
| Organ Specificity | 3 | 2018 | 310 | 0.070 |
Why?
|
| Hypertension | 1 | 2017 | 1280 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2016 | 2542 | 0.070 |
Why?
|
| Exosomes | 1 | 2009 | 104 | 0.070 |
Why?
|
| Oleic Acid | 1 | 2008 | 40 | 0.070 |
Why?
|
| Metabolome | 2 | 2024 | 391 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2008 | 105 | 0.070 |
Why?
|
| Seasons | 2 | 2026 | 540 | 0.070 |
Why?
|
| Kidney Function Tests | 2 | 2019 | 156 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2008 | 567 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2020 | 8164 | 0.070 |
Why?
|
| Tissue Distribution | 3 | 2007 | 335 | 0.070 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2019 | 121 | 0.070 |
Why?
|
| Dietary Supplements | 2 | 2026 | 586 | 0.060 |
Why?
|
| Adiposity | 2 | 2015 | 533 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2020 | 323 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2026 | 695 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 33 | 0.060 |
Why?
|
| Vasotocin | 1 | 2006 | 5 | 0.060 |
Why?
|
| Affinity Labels | 3 | 1992 | 16 | 0.060 |
Why?
|
| Muscle, Smooth | 2 | 2019 | 153 | 0.060 |
Why?
|
| Urethane | 1 | 2007 | 43 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2020 | 891 | 0.060 |
Why?
|
| Muscle Tonus | 1 | 2006 | 24 | 0.060 |
Why?
|
| Lipogenesis | 2 | 2018 | 62 | 0.060 |
Why?
|
| Uterine Contraction | 1 | 2006 | 17 | 0.060 |
Why?
|
| Sugar Phosphates | 1 | 1986 | 3 | 0.060 |
Why?
|
| Prostaglandins | 1 | 2006 | 94 | 0.060 |
Why?
|
| Lizards | 1 | 2006 | 43 | 0.060 |
Why?
|
| Azides | 3 | 1992 | 49 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2020 | 680 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2014 | 162 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2008 | 420 | 0.060 |
Why?
|
| Reperfusion | 1 | 2026 | 54 | 0.060 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2026 | 15 | 0.060 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2026 | 12 | 0.060 |
Why?
|
| Risk Factors | 1 | 2020 | 11017 | 0.060 |
Why?
|
| Cyclopropanes | 1 | 2026 | 84 | 0.060 |
Why?
|
| Amidinotransferases | 2 | 2016 | 2 | 0.060 |
Why?
|
| Guanidinoacetate N-Methyltransferase | 2 | 2016 | 4 | 0.060 |
Why?
|
| Cathelicidins | 1 | 2025 | 40 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2025 | 74 | 0.060 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2025 | 15 | 0.060 |
Why?
|
| S-Adenosylhomocysteine | 2 | 2016 | 24 | 0.060 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2025 | 46 | 0.060 |
Why?
|
| Chemokine CXCL1 | 1 | 2025 | 76 | 0.060 |
Why?
|
| L-Gulonolactone Oxidase | 1 | 2025 | 2 | 0.060 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2019 | 175 | 0.060 |
Why?
|
| Kidney Glomerulus | 2 | 2018 | 125 | 0.060 |
Why?
|
| Tripartite Motif Proteins | 1 | 2025 | 39 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2005 | 17 | 0.060 |
Why?
|
| S-Adenosylmethionine | 2 | 2016 | 59 | 0.060 |
Why?
|
| Bacterial Translocation | 1 | 2025 | 52 | 0.060 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2026 | 146 | 0.060 |
Why?
|
| Aminopyridines | 1 | 2026 | 129 | 0.060 |
Why?
|
| Bone Marrow | 1 | 2007 | 310 | 0.060 |
Why?
|
| Diethylnitrosamine | 1 | 2025 | 6 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 443 | 0.050 |
Why?
|
| Perilipin-1 | 2 | 2019 | 16 | 0.050 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2026 | 121 | 0.050 |
Why?
|
| Benzamides | 1 | 2026 | 227 | 0.050 |
Why?
|
| DNA Replication | 1 | 1987 | 250 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2011 | 1844 | 0.050 |
Why?
|
| Bacteroidetes | 1 | 2024 | 21 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2020 | 475 | 0.050 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 31 | 0.050 |
Why?
|
| Liver Regeneration | 1 | 2024 | 46 | 0.050 |
Why?
|
| Fructosephosphates | 1 | 2024 | 2 | 0.050 |
Why?
|
| Adenoma | 1 | 2007 | 219 | 0.050 |
Why?
|
| Muscular Atrophy | 1 | 2025 | 87 | 0.050 |
Why?
|
| Edema | 2 | 2017 | 128 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2026 | 367 | 0.050 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2024 | 27 | 0.050 |
Why?
|
| Ileitis | 1 | 2024 | 33 | 0.050 |
Why?
|
| Triazoles | 1 | 2026 | 191 | 0.050 |
Why?
|
| Tamoxifen | 2 | 2020 | 193 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2024 | 37 | 0.050 |
Why?
|
| Macrophage Activation Syndrome | 1 | 2024 | 22 | 0.050 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 1107 | 0.050 |
Why?
|
| Oxygen Consumption | 2 | 2018 | 721 | 0.050 |
Why?
|
| Diet, Fat-Restricted | 2 | 2015 | 79 | 0.050 |
Why?
|
| Cyclic GMP | 2 | 2019 | 90 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 599 | 0.050 |
Why?
|
| Rats, Wistar | 2 | 2016 | 450 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 1998 | 1046 | 0.050 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2024 | 40 | 0.050 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2024 | 65 | 0.050 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2023 | 3 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2024 | 54 | 0.050 |
Why?
|
| Anaerobiosis | 1 | 2024 | 65 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 2 | 2015 | 167 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2025 | 212 | 0.050 |
Why?
|
| Genes, Regulator | 1 | 2023 | 35 | 0.050 |
Why?
|
| ARNTL Transcription Factors | 1 | 2023 | 17 | 0.050 |
Why?
|
| Glycoside Hydrolases | 1 | 2023 | 38 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2025 | 199 | 0.050 |
Why?
|
| Macrophages, Alveolar | 1 | 2007 | 377 | 0.050 |
Why?
|
| Acute-Phase Reaction | 1 | 2023 | 37 | 0.050 |
Why?
|
| Transcription Factor RelA | 1 | 2024 | 93 | 0.050 |
Why?
|
| Mammary Glands, Human | 2 | 2016 | 71 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 376 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2025 | 244 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 1794 | 0.050 |
Why?
|
| Furosemide | 1 | 2023 | 37 | 0.050 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2023 | 23 | 0.050 |
Why?
|
| Carbon | 1 | 2024 | 176 | 0.050 |
Why?
|
| Respiration | 1 | 2024 | 208 | 0.050 |
Why?
|
| Time Factors | 5 | 2015 | 7173 | 0.050 |
Why?
|
| Lipocalin-2 | 1 | 2023 | 80 | 0.050 |
Why?
|
| Receptors, Interferon | 1 | 2023 | 60 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2024 | 234 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2005 | 261 | 0.050 |
Why?
|
| RNA, Transfer | 1 | 2024 | 143 | 0.050 |
Why?
|
| Folic Acid | 1 | 2024 | 198 | 0.050 |
Why?
|
| Wnt Signaling Pathway | 1 | 2024 | 212 | 0.050 |
Why?
|
| Cell Survival | 4 | 2014 | 1111 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2003 | 192 | 0.050 |
Why?
|
| Chemokine CCL7 | 1 | 2022 | 1 | 0.040 |
Why?
|
| Buthionine Sulfoximine | 1 | 2022 | 9 | 0.040 |
Why?
|
| Inhibitor of Apoptosis Proteins | 4 | 2003 | 46 | 0.040 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1996 | 18 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 194 | 0.040 |
Why?
|
| Rats, Inbred F344 | 2 | 1992 | 269 | 0.040 |
Why?
|
| Fluorine | 2 | 1992 | 18 | 0.040 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2001 | 12 | 0.040 |
Why?
|
| Cervix Uteri | 1 | 2002 | 50 | 0.040 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2021 | 11 | 0.040 |
Why?
|
| Salmonella typhimurium | 1 | 2024 | 193 | 0.040 |
Why?
|
| Sterols | 1 | 2021 | 20 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2007 | 387 | 0.040 |
Why?
|
| Interferons | 1 | 2023 | 186 | 0.040 |
Why?
|
| Adenoviruses, Human | 1 | 2001 | 26 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 2030 | 0.040 |
Why?
|
| Benzimidazoles | 1 | 2023 | 190 | 0.040 |
Why?
|
| Immune Sera | 2 | 1992 | 77 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2025 | 397 | 0.040 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2002 | 71 | 0.040 |
Why?
|
| Systems Analysis | 1 | 2021 | 23 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2023 | 188 | 0.040 |
Why?
|
| Muscle, Skeletal | 2 | 2025 | 1798 | 0.040 |
Why?
|
| Sodium Glutamate | 1 | 2021 | 12 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 80 | 0.040 |
Why?
|
| Biomechanical Phenomena | 1 | 2025 | 873 | 0.040 |
Why?
|
| PAX6 Transcription Factor | 1 | 2021 | 21 | 0.040 |
Why?
|
| Antigens, CD | 2 | 2005 | 562 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2021 | 43 | 0.040 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 167 | 0.040 |
Why?
|
| Dilatation | 1 | 2022 | 73 | 0.040 |
Why?
|
| Pyridines | 1 | 2026 | 610 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2021 | 70 | 0.040 |
Why?
|
| Homeostasis | 2 | 2016 | 651 | 0.040 |
Why?
|
| Bilirubin | 1 | 2021 | 102 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2002 | 130 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2026 | 748 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2021 | 125 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2001 | 93 | 0.040 |
Why?
|
| Cation Exchange Resins | 1 | 2001 | 7 | 0.040 |
Why?
|
| Histological Techniques | 1 | 2021 | 39 | 0.040 |
Why?
|
| Infliximab | 1 | 2021 | 111 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2021 | 139 | 0.040 |
Why?
|
| Polylysine | 1 | 2001 | 15 | 0.040 |
Why?
|
| Silicon Dioxide | 1 | 2022 | 119 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 2001 | 106 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2005 | 1253 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 201 | 0.040 |
Why?
|
| Ischemia | 1 | 2024 | 424 | 0.040 |
Why?
|
| Drinking | 1 | 2021 | 44 | 0.040 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2020 | 17 | 0.040 |
Why?
|
| Intestine, Large | 1 | 2020 | 13 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2025 | 1140 | 0.040 |
Why?
|
| Plant Oils | 1 | 2000 | 33 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 430 | 0.040 |
Why?
|
| Intercellular Junctions | 1 | 2020 | 35 | 0.040 |
Why?
|
| Receptors, Purinergic P2X2 | 1 | 2020 | 15 | 0.040 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2020 | 7 | 0.040 |
Why?
|
| Fluorescence | 1 | 2001 | 161 | 0.040 |
Why?
|
| Receptors, Purinergic P2X3 | 1 | 2020 | 15 | 0.040 |
Why?
|
| Pyrones | 1 | 2020 | 11 | 0.040 |
Why?
|
| Calcium | 1 | 2006 | 1197 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2024 | 679 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2024 | 262 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 334 | 0.040 |
Why?
|
| Morphogenesis | 1 | 2021 | 171 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2020 | 93 | 0.040 |
Why?
|
| Proteostasis | 1 | 2020 | 32 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 246 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 566 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2021 | 210 | 0.040 |
Why?
|
| Lactobacillus | 1 | 2020 | 28 | 0.040 |
Why?
|
| Cecum | 1 | 2020 | 37 | 0.040 |
Why?
|
| Permeability | 1 | 2020 | 170 | 0.040 |
Why?
|
| Leukocytes | 1 | 2022 | 301 | 0.040 |
Why?
|
| RNA | 2 | 2024 | 916 | 0.040 |
Why?
|
| Streptococcus pneumoniae | 1 | 2022 | 190 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2020 | 67 | 0.040 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 32 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2022 | 222 | 0.040 |
Why?
|
| R-SNARE Proteins | 1 | 2019 | 19 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2020 | 108 | 0.040 |
Why?
|
| Ki-67 Antigen | 2 | 2016 | 120 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2001 | 172 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2020 | 112 | 0.040 |
Why?
|
| Feeding Behavior | 2 | 2018 | 693 | 0.040 |
Why?
|
| Pituitary Gland | 1 | 2020 | 149 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2021 | 394 | 0.040 |
Why?
|
| Thiophenes | 1 | 2020 | 117 | 0.040 |
Why?
|
| Purines | 1 | 2020 | 188 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2020 | 193 | 0.040 |
Why?
|
| Binding Sites | 1 | 2003 | 1319 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2023 | 765 | 0.040 |
Why?
|
| Polymers | 2 | 2014 | 486 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 2020 | 201 | 0.040 |
Why?
|
| Uncoupling Protein 1 | 1 | 2019 | 17 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2020 | 145 | 0.040 |
Why?
|
| Iodide Peroxidase | 1 | 2019 | 35 | 0.040 |
Why?
|
| Food Preferences | 1 | 2020 | 126 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2019 | 64 | 0.040 |
Why?
|
| Photoperiod | 1 | 2019 | 55 | 0.040 |
Why?
|
| Parasite Load | 1 | 2018 | 10 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2022 | 1046 | 0.040 |
Why?
|
| Leishmania donovani | 1 | 2018 | 12 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2003 | 698 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2002 | 268 | 0.040 |
Why?
|
| Desmoglein 3 | 1 | 2018 | 14 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2019 | 92 | 0.030 |
Why?
|
| gamma Catenin | 1 | 2018 | 13 | 0.030 |
Why?
|
| Sirtuins | 1 | 2019 | 50 | 0.030 |
Why?
|
| Protein Binding | 3 | 2011 | 2249 | 0.030 |
Why?
|
| Metaplasia | 1 | 2018 | 57 | 0.030 |
Why?
|
| Bronchial Diseases | 1 | 2018 | 38 | 0.030 |
Why?
|
| Alanine | 1 | 2019 | 173 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 187 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2018 | 85 | 0.030 |
Why?
|
| Sirtuin 3 | 1 | 2019 | 60 | 0.030 |
Why?
|
| Protein Transport | 1 | 2019 | 442 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2018 | 105 | 0.030 |
Why?
|
| Cholic Acids | 1 | 2017 | 13 | 0.030 |
Why?
|
| Glomerular Mesangium | 1 | 2017 | 21 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2018 | 97 | 0.030 |
Why?
|
| Sarcopenia | 1 | 2019 | 92 | 0.030 |
Why?
|
| Ribosomes | 1 | 2019 | 193 | 0.030 |
Why?
|
| Adiponectin | 2 | 2013 | 244 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1998 | 122 | 0.030 |
Why?
|
| Azo Compounds | 1 | 2017 | 30 | 0.030 |
Why?
|
| Bacteria | 1 | 2023 | 769 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2017 | 182 | 0.030 |
Why?
|
| Virulence | 1 | 2018 | 286 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2017 | 59 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2018 | 296 | 0.030 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2017 | 1 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2017 | 76 | 0.030 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.030 |
Why?
|
| Urinalysis | 1 | 2017 | 83 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2011 | 200 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 939 | 0.030 |
Why?
|
| DNA | 5 | 1986 | 1444 | 0.030 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2016 | 20 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 367 | 0.030 |
Why?
|
| Erythema | 1 | 2017 | 28 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 171 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2013 | 1606 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2018 | 188 | 0.030 |
Why?
|
| Staining and Labeling | 2 | 1992 | 153 | 0.030 |
Why?
|
| Islets of Langerhans | 1 | 2003 | 853 | 0.030 |
Why?
|
| Podocytes | 1 | 2017 | 80 | 0.030 |
Why?
|
| Adenine | 1 | 2019 | 339 | 0.030 |
Why?
|
| Indomethacin | 2 | 2006 | 77 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 500 | 0.030 |
Why?
|
| Butyrophilins | 1 | 2016 | 5 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 507 | 0.030 |
Why?
|
| Albuminuria | 1 | 2017 | 189 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2020 | 518 | 0.030 |
Why?
|
| Bronchi | 1 | 2018 | 263 | 0.030 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1996 | 5 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 2016 | 77 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 525 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2016 | 86 | 0.030 |
Why?
|
| Hybrid Cells | 1 | 1996 | 49 | 0.030 |
Why?
|
| Okadaic Acid | 1 | 1996 | 15 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2016 | 91 | 0.030 |
Why?
|
| Connective Tissue | 1 | 2016 | 38 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 158 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 849 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 49 | 0.030 |
Why?
|
| Lentivirus | 1 | 2016 | 62 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 1996 | 99 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2016 | 97 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 451 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 1151 | 0.030 |
Why?
|
| Systems Biology | 1 | 2016 | 68 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2016 | 142 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 1875 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 2110 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 222 | 0.030 |
Why?
|
| Deoxyguanosine | 1 | 2015 | 25 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2017 | 337 | 0.030 |
Why?
|
| Chemokine CXCL2 | 1 | 2014 | 41 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 1996 | 512 | 0.030 |
Why?
|
| Catalysis | 1 | 2016 | 305 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 627 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 31 | 0.030 |
Why?
|
| Cytochrome P-450 CYP4A | 1 | 2014 | 4 | 0.030 |
Why?
|
| Kidney Cortex | 1 | 2014 | 27 | 0.030 |
Why?
|
| Comet Assay | 1 | 2014 | 14 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 327 | 0.030 |
Why?
|
| Fatty Acid Synthases | 1 | 2014 | 23 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 337 | 0.030 |
Why?
|
| CD36 Antigens | 1 | 2014 | 32 | 0.030 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2014 | 88 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 1172 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 2017 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 1 | 2014 | 95 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2015 | 398 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 633 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 138 | 0.030 |
Why?
|
| Kinetics | 3 | 1987 | 1569 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2014 | 319 | 0.030 |
Why?
|
| Progesterone | 2 | 1987 | 215 | 0.030 |
Why?
|
| Skinfold Thickness | 1 | 2013 | 43 | 0.030 |
Why?
|
| RNA Interference | 1 | 2016 | 477 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2017 | 675 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 120 | 0.020 |
Why?
|
| Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.020 |
Why?
|
| Central Nervous System Depressants | 1 | 2014 | 84 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1996 | 780 | 0.020 |
Why?
|
| Tetraspanin 28 | 2 | 2005 | 6 | 0.020 |
Why?
|
| Tongue | 1 | 2013 | 77 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2016 | 445 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 133 | 0.020 |
Why?
|
| Binding, Competitive | 3 | 1992 | 185 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1996 | 726 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 27 | 0.020 |
Why?
|
| Ketone Bodies | 1 | 2013 | 16 | 0.020 |
Why?
|
| Leydig Cells | 1 | 1992 | 15 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 512 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 2009 | 589 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2018 | 489 | 0.020 |
Why?
|
| Antigens, CD1d | 1 | 2013 | 69 | 0.020 |
Why?
|
| Aldehyde Reductase | 1 | 2013 | 31 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2014 | 251 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 597 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1993 | 180 | 0.020 |
Why?
|
| Theca Cells | 1 | 1992 | 2 | 0.020 |
Why?
|
| Computational Biology | 1 | 2017 | 677 | 0.020 |
Why?
|
| Species Specificity | 1 | 2013 | 547 | 0.020 |
Why?
|
| Antibodies | 1 | 2014 | 398 | 0.020 |
Why?
|
| Actins | 1 | 2014 | 428 | 0.020 |
Why?
|
| alpha-Macroglobulins | 1 | 2012 | 25 | 0.020 |
Why?
|
| Transcriptome | 1 | 2019 | 1059 | 0.020 |
Why?
|
| Models, Biological | 2 | 2011 | 1772 | 0.020 |
Why?
|
| Sex Factors | 1 | 2018 | 2136 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 5476 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 762 | 0.020 |
Why?
|
| Caseins | 1 | 2011 | 20 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2019 | 6543 | 0.020 |
Why?
|
| Palmitic Acid | 1 | 2011 | 40 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2012 | 147 | 0.020 |
Why?
|
| Mucous Membrane | 2 | 2002 | 130 | 0.020 |
Why?
|
| Amino Acids | 1 | 2015 | 519 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2014 | 1386 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4383 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2018 | 663 | 0.020 |
Why?
|
| Acyltransferases | 1 | 2011 | 78 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 593 | 0.020 |
Why?
|
| Body Temperature | 1 | 2012 | 229 | 0.020 |
Why?
|
| Retinal Dehydrogenase | 1 | 2011 | 29 | 0.020 |
Why?
|
| Lipase | 1 | 2011 | 76 | 0.020 |
Why?
|
| Membranes, Artificial | 1 | 2011 | 68 | 0.020 |
Why?
|
| Tritium | 1 | 1990 | 67 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 82 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2017 | 1785 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 1990 | 48 | 0.020 |
Why?
|
| Baculoviridae | 1 | 2010 | 44 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 2231 | 0.020 |
Why?
|
| Insulin | 2 | 2016 | 2526 | 0.020 |
Why?
|
| Mitochondria, Liver | 1 | 2010 | 70 | 0.020 |
Why?
|
| Oxidants | 1 | 2010 | 99 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 156 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 143 | 0.020 |
Why?
|
| Hydrolysis | 1 | 1990 | 197 | 0.020 |
Why?
|
| Insecta | 1 | 2010 | 73 | 0.020 |
Why?
|
| NAD | 1 | 2010 | 79 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 383 | 0.020 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2009 | 25 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 1990 | 104 | 0.020 |
Why?
|
| Cytosol | 1 | 2010 | 213 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 572 | 0.020 |
Why?
|
| Transgenes | 1 | 2010 | 190 | 0.020 |
Why?
|
| HeLa Cells | 2 | 2001 | 633 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 1989 | 1049 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2009 | 112 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 672 | 0.020 |
Why?
|
| Plasmids | 1 | 2010 | 373 | 0.020 |
Why?
|
| Prostaglandins F, Synthetic | 1 | 1989 | 9 | 0.020 |
Why?
|
| Hypoxia | 1 | 2016 | 1208 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 76 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2008 | 48 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2008 | 156 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2008 | 107 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2009 | 451 | 0.020 |
Why?
|
| Random Allocation | 1 | 2008 | 366 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 745 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 874 | 0.020 |
Why?
|
| Palmitates | 1 | 2007 | 21 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 303 | 0.020 |
Why?
|
| Cell Movement | 2 | 2009 | 966 | 0.020 |
Why?
|
| Reflex, Stretch | 1 | 2006 | 11 | 0.020 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2007 | 66 | 0.020 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1986 | 4 | 0.020 |
Why?
|
| Vanadium | 1 | 1986 | 9 | 0.020 |
Why?
|
| Carbachol | 1 | 1986 | 17 | 0.020 |
Why?
|
| Vanadates | 1 | 1986 | 17 | 0.020 |
Why?
|
| Prostaglandins E | 1 | 1986 | 33 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2007 | 362 | 0.010 |
Why?
|
| Thymidine | 1 | 1986 | 60 | 0.010 |
Why?
|
| Growth Substances | 1 | 1986 | 138 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2007 | 387 | 0.010 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 1986 | 73 | 0.010 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1986 | 52 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2008 | 1302 | 0.010 |
Why?
|
| PPAR gamma | 1 | 2007 | 182 | 0.010 |
Why?
|
| Exercise | 1 | 2018 | 2219 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1986 | 162 | 0.010 |
Why?
|
| Tetraspanins | 1 | 2005 | 19 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1986 | 180 | 0.010 |
Why?
|
| Detergents | 1 | 2005 | 43 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1986 | 208 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1986 | 105 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 8430 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2009 | 687 | 0.010 |
Why?
|
| Infant | 1 | 2019 | 10194 | 0.010 |
Why?
|
| Uteroglobin | 2 | 1984 | 31 | 0.010 |
Why?
|
| Solubility | 1 | 2005 | 240 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1987 | 300 | 0.010 |
Why?
|
| Introns | 1 | 2005 | 260 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 172 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 2458 | 0.010 |
Why?
|
| Metformin | 1 | 2007 | 329 | 0.010 |
Why?
|
| Testosterone | 1 | 1987 | 417 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 12016 | 0.010 |
Why?
|
| Glucagon | 1 | 2003 | 114 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 2 | 1979 | 166 | 0.010 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2002 | 27 | 0.010 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 51 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 318 | 0.010 |
Why?
|
| Papillomaviridae | 1 | 2002 | 116 | 0.010 |
Why?
|
| Photochemistry | 2 | 1992 | 127 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2007 | 1039 | 0.010 |
Why?
|
| Membrane Microdomains | 1 | 2000 | 34 | 0.010 |
Why?
|
| Sheep | 3 | 1992 | 879 | 0.010 |
Why?
|
| Fluorescent Dyes | 2 | 1979 | 342 | 0.010 |
Why?
|
| Polyribosomes | 1 | 1980 | 22 | 0.010 |
Why?
|
| Molecular Structure | 2 | 1992 | 488 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2001 | 177 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 216 | 0.010 |
Why?
|
| Keratins | 1 | 2001 | 171 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2002 | 357 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1980 | 120 | 0.010 |
Why?
|
| Gestational Age | 1 | 2003 | 997 | 0.010 |
Why?
|
| Cytological Techniques | 1 | 1979 | 27 | 0.010 |
Why?
|
| Thyroid Gland | 1 | 1980 | 93 | 0.010 |
Why?
|
| Chromomycins | 1 | 1978 | 1 | 0.010 |
Why?
|
| Olivomycins | 1 | 1978 | 1 | 0.010 |
Why?
|
| Plicamycin | 1 | 1978 | 3 | 0.010 |
Why?
|
| Fetus | 1 | 2003 | 805 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 22825 | 0.010 |
Why?
|
| Child | 1 | 2018 | 22979 | 0.010 |
Why?
|
| Papillomavirus Infections | 1 | 2002 | 345 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 1415 | 0.010 |
Why?
|
| Peptides, Cyclic | 1 | 1978 | 273 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2000 | 649 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1978 | 600 | 0.010 |
Why?
|
| Luteal Cells | 1 | 1992 | 3 | 0.010 |
Why?
|
| Esters | 1 | 1992 | 71 | 0.010 |
Why?
|
| Chemistry | 1 | 1989 | 41 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1989 | 77 | 0.000 |
Why?
|
| Estrogen Antagonists | 1 | 1984 | 37 | 0.000 |
Why?
|
| Poly A | 1 | 1980 | 50 | 0.000 |
Why?
|
| RNA, Ribosomal | 1 | 1980 | 168 | 0.000 |
Why?
|
| Fixatives | 1 | 1978 | 13 | 0.000 |
Why?
|
| Leukemia, Experimental | 1 | 1978 | 27 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1978 | 168 | 0.000 |
Why?
|
| Cricetinae | 1 | 1978 | 305 | 0.000 |
Why?
|
| Magnesium | 1 | 1978 | 157 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1978 | 536 | 0.000 |
Why?
|